STAAR Surgical Co (NASDAQ: STAA) suffers from exceptional negative changes in investment behavior: the stock’s recent price decline challenged its longer term uptrend, the stock fell on very heavy volume, and negative upside/downside volume developed.
Recent slight negative changes in fundamentals have impacted STAAR Surgical Co (NASDAQ: STAA): the consensus estimate for December, 2024 decreased significantly.
In light of these highly negative signals we are reviewing our current Overall Rating of C. We would view the shares with caution pending completion of this review in the next several days.
Current PriceTarget Research Rating
With future capital returns forecasted to exceed the cost of capital, STAA is expected to continue to be a modest Value Builder.
STAAR Surgical has a current Value Trend Rating of C (Neutral). This rating combines very contradictory signals from two proprietary PTR measures of a stock’s attractiveness. STAAR Surgical has a poor Appreciation Score of 17 but a very high Power Rating of 86, and the Neutral Value Trend Rating results.
Recent Price Action
STAAR Surgical Co (NASDAQ: STAA) stock suffered a large decline of -5.1% on 8/5/24. The stock closed at $37.00. Moreover, exceptionally high trading volume at 323% of normal accompanied the decline. Relative to the market the stock has been exceptionally strong over the last nine months but has declined -7.7% during the last week.
Be the first to comment